Oral vinorelbine: a practical approach to patient management
CPD    

Oral vinorelbine: a practical approach to patient management

Mark Foulkes Nurse consultant in cancer care/trust lead cancer nurse, Berkshire Cancer Centre, Royal Berkshire NHS Foundation Trust, Reading, England
Carole Farrell Teaching fellow/honorary lecturer, University of Manchester, Manchester, England
Thomas Allum Macmillan patient information and support service manager, Imperial College Healthcare NHS Trust, London, England
Jane Beveridge Deputy nurse director, Weston Park Hospital, Sheffield, England
Victoria Harmer Consultant nurse in breast care, Imperial College Healthcare NHS Trust, London, England

Oral vinorelbine has been a well-established cytotoxic treatment for non-small cell lung cancer and metastatic breast cancer since 2004. This article summarises the applications of the drug, the advantages and challenges of using an oral agent in palliative oncology settings and how oral vinorelbine has been used to develop nurse-led services and chemotherapy outside traditional hospital environments. The article includes two case studies to place this treatment in a clinical context.

Cancer Nursing Practice. doi: 10.7748/cnp.2018.e1467

Citation

Foulkes M, Farrell C, Allum T et al (2018) Oral vinorelbine: a practical approach to patient management. Cancer Nursing Practice. doi: 10.7748/cnp.2018.e1467

Peer review

This article has been subject to external double-blind peer review and checked for plagiarism using automated software

Correspondence

mark.foulkes@royalberkshire.nhs.uk

Conflict of interest

Mark Foulkes has previously received honoraria for consultancy and advisory roles for Pierre Fabre Ltd

Published online: 02 May 2018

You need a subscription to read the full article